Skip to main content

NIH recovery grants top $5 billion

Grants to be announced today (September 30) will bring the total amount of recovery act funding spent by the National Institutes of Health to more than $5 billion, top officials said this morning. The NIH has awarded 12,000 biomedical research grants since the the American Recovery and Reinvestment Act of 2009 was passed in February. An linkurl:analysis;https://www.aaas.org/spp/rd/ARRA/ published last week by the American Association for the Advancement of Science indicated that the NIH had awar

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Grants to be announced today (September 30) will bring the total amount of recovery act funding spent by the National Institutes of Health to more than $5 billion, top officials said this morning. The NIH has awarded 12,000 biomedical research grants since the the American Recovery and Reinvestment Act of 2009 was passed in February. An linkurl:analysis;https://www.aaas.org/spp/rd/ARRA/ published last week by the American Association for the Advancement of Science indicated that the NIH had awarded only about $2.6 billion of the $10.4 billion it netted in the recovery act. Today's announcement adds almost $3 billion in awarded funding to that figure. "I am confident that millions of Americans alive today, and millions more in the future, will live longer and healthier lives because of the grants we announce today," said NIH director Francis Collins, speaking today at the agency's Bethesda, Maryland campus. Collins added that more than 1800 of the grant awardees had not received prior NIH funding. President Barack Obama -- who Collins introduced as the "Scientist in Chief" -- was also on hand in Bethesda to celebrate the announcement. "This represents the single largest boost to biomedical research in history," Obama said to a crowded NIH auditorium that also held Senator Arlen Specter (D-PA), Department of Health and Human Services Secretary Kathleen Sebelius, National Institute of Allergy and Infectious Diseases director Anthony Fauci, and others. Obama highlighted the promise of applying knowledge gained through studying the human genome to three disease areas: cancer, heart disease, and autism. "It's a promise we've only just begun to realize," he said. He noted that recovery act funding -- $175 million, according to the NIH -- will help expand the NIH's Cancer Genome Atlas, which will seek to collect more than 20,000 new tissue samples from more than 20 different types of cancer over the next two years. The president also mentioned that linkurl:Framingham Heart Study;https://www.framinghamheartstudy.org/ researchers can now begin to correlate the genomic profiles of participants with decades of observational data to start developing heart disease prevention and treatment strategies. Obama added that recovery spending would not only benefit biomedical research and medicine but would also buoy the nation's wider economy. "We can only imagine the new discoveries that will flow from the investments we make today," he said. "But we also know that these investments will save jobs and create new jobs." Obama even managed to squeeze in his standard health care reform pitch, telling the crowd that his plan did not amount to a government takeover of the health care system and that a reformed system depended on and would benefit from a strong and vibrant NIH. Obama closed by promising the assembled NIH staffers that his administration's commitment to biomedical research would not wane. "We are going to keep on providing the support that you need," he said.
**__Related stories:__***linkurl:Collins prepares for budget battle;https://www.the-scientist.com/blog/display/55891/
[17th August 2009]*linkurl:Bailed Out by Science;https://www.the-scientist.com/article/display/55840/
[August 2009]*linkurl:Your guide to NIH stimulus funds;https://www.the-scientist.com/blog/display/55588/
[2nd April 2009]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi
Mapping Clonal Mosaicism in Aging Tissues

Mapping Clonal Mosaicism in Aging Tissues

Mission bio

Products

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo
Conceptual image of ice and frost.

The VAULT100 PRO: Inside the most advanced Stirling Ultracold ULT freezer ever built.

Stirling Ultracold logo